Complementary Medicines Australia says it applauds Blackmores, for supporting independent complementary medicine research via the donation of $1.3 million to the University of Sydney to fund the Maurice Blackmore Chair in Integrative Medicine.
Chief executive officer of CMA Carl Gibson says it is commendable to see Blackmores donating funds towards education of student doctors about complementary medicines and how they interact with conventional treatments.
“With around 70% of the Australian population using complementary medicines, it is crucial that doctors and other primary healthcare professionals are able to discuss the use of these medicines with their patients,” says Gibson.
“Complementary medicines are used as part of a preventive health regime or in conjunction with conventional treatments, and this needs to be acknowledged and incorporated into medical training.”
A viable and innovative complementary medicines industry is dependent on research to support quality, safety, efficacy, and cost-effectiveness, he says.
“This donation from Blackmores highlights the willingness of industry to work with researchers and with government to continue to grow the body of evidence for complementary medicines.
“The goals of this initiative, including assisting doctors in making informed decisions about complementary medicines, are perfectly aligned with the intentions of the WHO Traditional Medicine Strategy 2014-2023; to harness the potential that complementary medicines can make to health and wellness and to the appropriate integration of complementary medicines into the health care system,” says Gibson.